Measure Labs, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Discharge Readmission Analysis and Management in Sepsis (DReAMS-2) (NCT06099756) | Measure Labs, Inc. | 2023-10-26 |
Track Measure Labs, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.